Reply to Andreas Boehle, Frank Kahmann, Thomas Oliver Henkel, Joerg Zimmermann and Stefan Machten’s to the Letter to the editor Re: results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial)

Detalles Bibliográficos
Autores principales: Wiegel, Thomas, Albers, Peter, Bartkowiak, Detlef, Bussar-Maatz, Roswitha, Härter, Martin, Kristiansen, Glen, Martus, Peter, Wellek, Stefan, Schmidberger, Heinz, Grozinger, Klaus, Renner, Peter, Schneider, Fried, Burmester, Martin, Stöckle, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7954727/
https://www.ncbi.nlm.nih.gov/pubmed/33625578
http://dx.doi.org/10.1007/s00432-021-03549-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7954727/
https://www.ncbi.nlm.nih.gov/pubmed/33625578
http://dx.doi.org/10.1007/s00432-021-03549-y

Ejemplares similares